Objectives: Bone marrow specimens (aspirate and core biopsy) are invaluable in the diagnosis of hematologic disorders. These can be obtained via the traditional manual needle method (such as the Jamshedi) or the newly developed powered drills, which our teaching institution has recently started using. This study is aimed at comparing the adequacy of bone marrow specimens for pathologic examination obtained from adult patients via the standard manual technique to a powered drill and thereby providing valuable feedback to our clinical colleagues. Methods: A total of 245 serial bone marrow specimens (125 manual and 120 powered) performed by 13 hematology-oncology fellows were included. The specimen quality was obtained by retrospective review of pathology reports that includes information on quality and adequacy of specimens based on presence of particles for aspirate, and presence of at least 10 mm of evaluable marrow in core biopsy. Results: Out of 125 manual marrow aspirate procedures, 77% were adequate for evaluation. Out of 120 powered marrow aspirate procedures, 75% were adequate for evaluation. Of a total of 145 manual core biopsies, 70% were adequate, and of 100 powered core biopsies, 60% were adequate. Conclusion: Our results indicate that both manual and powered bone marrow procedures yield similarly adequate specimens for pathologic evaluation. These results are reassuring and support the continued use of the powered technique in our large teaching institution, as powered techniques have been reported to be more user friendly (less time and more ergonomic) and, more importantly, result in significantly less pain for the patients. Large-scale normative data are lacking for benign lymph nodes assessed by flow cytometry immunophenotyping. Initial diagnostics are increasingly moving toward fine needle aspiration (FNA). We used a novel informatics approach to gather large-scale normative data for benign lymph node flow cytometry and compare the performance of flow cytometry immunophenotyping from samples obtained by excisional biopsy vs FNA. We hypothesized that a large normative immunophenotyping dataset will demonstrate comparability between excisional biopsies and FNA flow cytometry immunophenotyping results. Custom text-parsing software was created to extract clinical, diagnostic, and flow cytometry data from 382 consecutive excisional biopsies and 309 consecutive FNAs carrying a benign diagnosis and spanning the last 15 years. Antigens normalized to B-and T-cell content were compared between excisional biopsy and FNAs by t-test corrected for multiple comparisons by false discovery rate. As expected, raw numbers of events were lower in the FNA as compared to the excisional biopsies (86.0% vs 82%). Excisional biopsy vs FNA samples had a significantly lower proportion of events in the monocyte gate (6.5% vs 4.3%). FNAs were enriched for CD3+ T cell events (70.1% vs 59.4%) and with proportionately fewer CD19+ B cells events (23.8% vs 32.7%). Nevertheless, normalized B-cell subsets (eg, %CD19/CD10+, %CD19/ CD5+) and T-cell subsets (eg, CD4:CD8 ratio) did not significantly differ between excisional biopsy and FNA specimens with minor exceptions. In conclusion, excisional biopsy and FNA samples differ in overall yield as well as T-cell content, likely due to peripheral blood contamination, but nevertheless produce comparable immunophenotyping results with respect to B-and T-cell subsets in benign lymph nodes. Informatics approaches enlarge normative datasets and in the current study led to the first large-scale quantitative comparison of normative data between different tissue-sampling methods. Objective: Mutations in nucleophosmin (NPM1) are present in one-third of AML patients and are considered a favorable prognostic marker. Several AML patients with mutated NPM1 exhibit monocytic differentiation. Given that a significant number of patients with AML FAB-M4 and M5 have increased bone marrow reticulin fibrosis, we sought to investigate a relationship between newly diagnosed AML with mutated NPM1 and bone marrow fibrosis.
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